Pol F. Boudes

Insider Reports History

Entity
Individual
Location
C/O Cymabay Therapeutics, Inc., 7575 Gateway Blvd., Suite 110, Newark, CA
Signature
Jack W. Callicutt, by power of attorney
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Pol F. Boudes:

Stock Role Class Num Shares Value Price $ Report Date Ownership
GALECTIN THERAPEUTICS INC Chief Medical Officer Restricted Stock Unit 40K $71.4K $1.79 Jan 24, 2024 Direct
GALECTIN THERAPEUTICS INC Chief Medical Officer Stock Option (right to buy) 65K Jan 24, 2024 Direct
Protalix BioTherapeutics, Inc. Director Stock Options (Right to Buy) 61.7K Sep 29, 2023 Direct

Insider Reports Filed by Pol F. Boudes

Symbol Company Period Transactions Value $ Form Type Date Filed Role
GALT GALECTIN THERAPEUTICS INC Jan 24, 2024 2 $0 4 Feb 7, 2024 Chief Medical Officer
PLX Protalix BioTherapeutics, Inc. Sep 29, 2023 1 $0 4 Oct 3, 2023 Director
GALT GALECTIN THERAPEUTICS INC Jan 26, 2023 1 $0 4 Jan 30, 2023 Chief Medical Officer
PLX Protalix BioTherapeutics, Inc. Sep 7, 2022 1 $0 4 Sep 9, 2022 Director
GALT GALECTIN THERAPEUTICS INC Jan 24, 2022 1 $0 4 Jan 25, 2022 Chief Medical Officer